Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

NCT05420493 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Non-Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma
Non Hodgkin Lymphoma

Interventions

BIOLOGICAL: CAR-T cells

Sponsor

Chongqing Precision Biotech Co., Ltd